期刊文献+

早孕因子单克隆抗体对宫颈癌HeLa细胞增殖、迁移及凋亡的影响

Effects of monoclonal antibody against early pregnancy factor on proliferation,migration and apoptosis of cervical cancer HeLa cells
暂未订购
导出
摘要 通过研究早孕因子单克隆抗体EPF-B6对宫颈癌HeLa细胞增殖、迁移、克隆及凋亡的影响,探讨EPF单抗对宫颈癌细胞生物学行为的抑制作用。利用RT-PCR及Western Blot检测等6种常见肿瘤细胞中EPF基因及细胞培养液中EPF蛋白表达;CCK8、细胞划痕、平板克隆分别检测不同浓度的EPF-B6单抗对HeLa细胞增殖、迁移与群体依赖性的影响;流式细胞术检测HeLa细胞凋亡与周期。结果表明,常见肿瘤细胞中均存在EPF基因,宫颈癌HeLa细胞、乳腺癌MCF-7细胞与人卵巢癌A2780细胞培养液中有EPF蛋白的表达;EPF-B6单抗能显著抑制HeLa细胞的增殖、迁移、克隆形成能力,呈现浓度依赖性(P<0.01)。细胞周期结果显示,EPF-B6单抗将HeLa细胞的DNA复制进程阻滞在G2/M期。 The inhibitory effect of monoclonal antibody against early pregnancy factor(EPF-B6)on the biological behavior of cervical cancer HeLa cells was investigated by studying the effects of EPF-B6 on the proliferation,migration,cloning and apoptosis of HeLa cells.RT-PCR and Western Blot were used to detect the expression of EPF gene in six common cancer cells and EPF protein in cell culture medium.The effects of different concentrations of EPF-B6 monoclonal antibody on the proliferation,migration and population dependence of HeLa cells were detected by CCK8 assay,cell scratch assay and plate cloning assay,respectively.The apoptosis and cycle of HeLa cells were detected by flow cytometry.Results showed that EPF gene was present in common tumor cells.EPF protein was expressed in the culture medium of cervical cancer HeLa cells,breast cancer MCF-7 cells and ovarian cancer A2780 cells.The results showed that EPF-B6 monoclonal antibody could significantly inhibit the proliferation,migration and colony formation of HeLa cells,it was concentration-dependent(P<0.01).The results of cell cycle analysis showed that EPF-B6 monoclonal antibody blocked the DNA replication process of HeLa cells at G2/M phase.
作者 段芙春 任洪林 胡盼 李岩松 柳溪林 王菡 刘蒙迪 李浩菘 卢士英 DUAN Fu-chun;REN Hong-lin;HU Pan;LI Yan-song;LIU Xi-lin;WANG Han;LIU Meng-di;LI Hao-song;LU Shi-ying(State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases/Key Laboratory of Zoonosis Research,Ministry of Education/Institute of Zoonosis/College of Veterinary Medicine,Jilin University,Changchun 130062,China)
出处 《湖北农业科学》 2025年第5期117-122,140,共7页 Hubei Agricultural Sciences
基金 国家自然科学基金面上项目(32072943)。
关键词 早孕因子 单克隆抗体 宫颈癌 HELA细胞 增殖 迁移 凋亡 early pregnancy factors monoclonal antibody cervical cancer Hela cells proliferation migration apoptosis
  • 相关文献

参考文献2

二级参考文献18

  • 1郭双平,王丽,王文亮,李擒龙,王文勇,张静.抑癌基因PTEN在肝癌组织中的突变及其对肝癌细胞增殖和凋亡的调控作用[J].中华病理学杂志,2006,35(8):467-472. 被引量:25
  • 2Viswanathan AN, Thomadsen B. American brachytherapy society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles [J]. Brachytherapy, 2012, 11(1): 33-46.
  • 3Levitchi M, Claire CB, Quetin P, et al. Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy[J]. Radiother Oncol, 2012, 103(3): 314-321.
  • 4Dimopoulos JC, Petrow P, Tanderup K, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy[J]. Radiother Oncol, 2012, 103(1): 113-122.
  • 5Uniyal SC, Sharma SD, Naithani UC. Dosimetric verification of a high dose rate brachytherapy treatment planning system in homogeneous and heterogeneous media[J]. Phys Med, 2013, 29(2): 171-177.
  • 6Viswanathan AN, Beriwal S, Santos JFDL, et al. American brachytherapy society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy[J]. Brachytherapy, 2012, 11(1): 47-52.
  • 7Miglierini P, Malhaire JP, Goasduff G, et al. Cervix cancer brachytherapy: high dose rate[J]. Cancer Radiother, 2014, 18(5-6): 452-457.
  • 8Mohamed S, Nielsen SK, Fokdal LU, et al. Feasibility of applyinga single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer[J]. Radiother Oncol, 2013, 107(1): 32-38.
  • 9Lang S, Nesvacil N, Kirisits C, et al. Uncertainty analysis for 3D image-based cervix cancer brachytherapy by repetitive MR imaging: ssessment of DVH-variations between two HDR fractions within one applicator insertion and their clinical relevance[J]. Radiother Oncol, 2013, 107(1): 26-31.
  • 10Petri P, Hudej R, Rogelj P, et al. Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: A multi-institutional study[J]. Radiother Oncol, 2013, 107( 1 ): 6-12.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部